ESCRE

This brand name is authorized in Japan

Active ingredients

The drug ESCRE contains one active pharmaceutical ingredient (API):

1 Chloral hydrate UNII 418M5916WG - CHLORAL HYDRATE
Chloral hydrate leads to a decrease in sleep latency and in the number of awakenings. A near natural sleep is induced and the REM/Non-REM ratio is not altered. Read about Chloral hydrate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CC01	Chloral hydrate	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CC Aldehydes and derivatives
Discover more medicines within N05CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: JP	医薬品医療機器総合機構	Identifier(s): 1123700J1020, 1123700J2027, 1123700X1023

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.